photo montage

New Business Opportunities for Science Thursday, April 26, 2007

Agenda

Schedule
4:00 - 4:15 p.m.
Welcome Remarks
4:15 - 5:30 p.m.
Cross-disciplinary teams

(comprised of students from the Business, Medical, Science, Engineering, Law, Government, and Public Health Schools) will present commercialization plans for university science research.

The format is a poster session; each project analyzes a real and current science commercialization opportunity from the listed labs and startups.

Participant Teams by Project Sponsor:

(click project titles to view posters)

Biotechnology

D. Fisher: "Complete Epigenetics Solution" — A novel technology to determine nucleosome locations in cell and tissue samples for development of novel pharmaceuticals and diagnostics.

C. Mitsiades: "High-Throughput Mixed-Culture Screen" A novel pre-clinical screening tool for analyzing tumor sensitivity to drugs in mixed cell cultures.

D. Mooney: "Controlled Cell Delivery" — Extracellular matrices to recruit, maintain and deliver cell therapies: tissue regeneration/repair to anti-cancer therapy.

G. Verdine: "RIPtides" — Novel oligonucleotide-based therapeutics targeting assembly of telomerase and other medically relevant biological targets.

Vertex Pharmaceuticals Inc.: "Hepatitis C Management" — Changing the patient management paradigm for transformational Hepatitis C virus treatments.

G. Whitesides: "Protein Sensing" — A novel separation technique for proteomic analysis and identification of biomarkers for disease.

Clean Technology

M. Aziz: "Carbon Neutral Power" —Technology that captures and stores carbon dioxide as solid crystals making traditional power plants climate friendly.

P. Girguis: "Microbial Fuel Cell" — Renewable, zero-pollution, and low cost and maintenance power sources for off-grid applications.

Information Technology

Icosystem Corp.: "The Hunch Engine Platform" — A licensable genetic algorithm for human creativity.

D. Parkes: "Cryptographic Securities Exchange" — Improved method for trading financial instruments that selectively conceals vulnerable trade information.

C. Kennedy: "Drug Discovery - Imaging & Informatics" — Two novel software programs for the automated analysis of neuronal morphologies to enable medical researchers to improve drug discovery.

Medical Device

C. Cutie: "Self-dilating Urethral Catheter" — Balloon-dilating catheter that patients can inflate to treat urethral strictures at home.

G. Gardner: "Pericardial Device" — Pericardial support device for advanced heart failure.

C. Marcus: "Molecular Imaging for MRI" — Using hyperpolarized silicon for molecular imaging.

K. Parker: "Molecular Scalpel" — Re-useable test to provide real-time diagnoses and guide medical treatment decisions with molecular precision.

M. Su: "Luminescence-based, Multi-metabolite Monitor" — Point of care device to optimize effective disease management.

A. Tavakkolizadeh: "Transluminal Surgery" — An alternative to laparoscopic surgery using novel technique and innovative medical devices for scarless access to the abdomen.

G. Whitesides: "Patterned Paper Diagnostics" — Low-cost point-of-care analysis of biological fluids: outpatient clinics to less-industrialized regions.

G. Whitesides: "Spectrally Tunable Laser" — Microfluidics technology that broadens the scope of laser-based clinical treatments using wavelength tunable light.